Savannah, Ga., December 10, 2018 — Michael Hemphill, MD, has received the 2018 Health Professional Impact Award from the National Multiple Sclerosis Society (NMSS). He is a principal investigator at Meridian Clinical Research, and has been a physician at Savannah Neurology Specialists in Savannah, Ga., since 1981.
The NMSS Health Professional Impact Award honors health professionals who have demonstrated their commitment to helping people with the challenges of multiple sclerosis by providing high-quality clinical care and serving in volunteer leadership positions. Dr. Hemphill received this award at an event in Atlanta, Ga.
As a patient advocate for those afflicted with multiple sclerosis, Dr. Hemphill serves on the board of directors of the NMSS Georgia Chapter, and has also been a member of the NMSS Healthcare Advisory Committee, providing guidance regarding the care and management of multiple sclerosis.
As a principal investigator, Dr. Hemphill has led numerous successful clinical trials and has written numerous journal articles. He frequently speaks as an expert on multiple sclerosis, migraine, epilepsy, and therapeutic uses of botulinum toxin.
Dr. Hemphill has been featured in Best Doctors in the Southeast and Best Doctors in America lists, and has received the Best Teacher of the Year Award from the Department of Family Medicine at Memorial University Medical Center several times.
To learn more about Dr. Hemphill and neurology clinical trials currently being conducted in Savannah, Ga., visit mcrmed.com.
About Meridian Clinical Research
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new pharmaceutical drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at a dedicated research center in Omaha, NE, and conducts Phase 1-4 studies at 18 investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. For more information, visit www.mcrmed.com.